Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 454

Similar articles for PubMed (Select 17056516)

1.
2.

VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.

Delgado M, Reduta A, Sharma V, Ganea D.

J Leukoc Biol. 2004 Jun;75(6):1122-30. Epub 2004 Mar 12.

3.
4.

Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.

Sun W, Hong J, Zang YC, Liu X, Zhang JZ.

Int Immunol. 2006 Dec;18(12):1691-700. Epub 2006 Oct 31.

5.

Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.

Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B.

J Immunol. 2001 Feb 15;166(4):2522-30.

6.

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Krug A, Rothenfusser S, Hornung V, Jahrsdörfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G.

Eur J Immunol. 2001 Jul;31(7):2154-63.

PMID:
11449369
8.

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.

Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, Blazar BR, Chen W.

J Immunol. 2004 Oct 1;173(7):4433-42.

9.
10.

VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.

Kojima M, Ito T, Oono T, Hisano T, Igarashi H, Arita Y, Kawabe K, Coy DH, Jensen RT, Nawata H.

Pancreas. 2005 Jan;30(1):62-70.

PMID:
15632701
11.

Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.

Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP.

Arthritis Rheum. 2008 Apr;58(4):1086-95. doi: 10.1002/art.23403.

PMID:
18383383
12.
13.

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F.

J Allergy Clin Immunol. 2004 Aug;114(2):436-43.

PMID:
15316529
15.

Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G.

J Immunol. 2003 May 1;170(9):4465-74.

16.

Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.

St Hilaire RC, Murthy SN, Kadowitz PJ, Jeter JR Jr.

Peptides. 2010 Aug;31(8):1517-22. doi: 10.1016/j.peptides.2010.04.024. Epub 2010 May 7.

PMID:
20452385
17.

Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes.

Qian BF, Hammarström ML, Danielsson A.

J Neuroendocrinol. 2001 Sep;13(9):818-25.

PMID:
11578532
18.

cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.

Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.

J Cell Physiol. 2009 Oct;221(1):75-83. doi: 10.1002/jcp.21831.

PMID:
19496170
20.

Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection.

Donhauser N, Helm M, Pritschet K, Schuster P, Ries M, Korn K, Vollmer J, Schmidt B.

AIDS Res Hum Retroviruses. 2010 Feb;26(2):161-71. doi: 10.1089/aid.2008.0278.

PMID:
20156099
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk